Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: WTO
The EU proposed Covid waivers of certain TRIPS rules are mostly...
Medicines Law & Policy
-
October 14, 2021
Ensuring that intellectual property rights aren’t a barrier to scaling-up: the...
Medicines Law & Policy
-
April 13, 2021
Wrapping up 2020 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 29, 2020
Decision on intellectual property waiver over Covid technology on hold till...
Kaitlin Mara
-
December 18, 2020
What is the ‘know-how gap’ problem and how might it impact...
Christopher Garrison
-
December 16, 2020
WTO Members discuss proposal to suspend certain intellectual property protection during...
Ellen 't Hoen
-
October 14, 2020
TRIPS Council to discuss IP and the public interest in the...
Ellen 't Hoen
-
July 29, 2020
Never say never – Why the High Income Countries that opted-out...
Christopher Garrison
-
April 8, 2020
Urgent collective action to meet the challenge of this pandemic crisis:...
Christopher Garrison
-
March 30, 2020
The Expanding Reach of the European Patent Office. Good for Health?
Ellen 't Hoen
-
March 18, 2020
1
2
3
Page 1 of 3
This work is licensed under Creative Commons.